Answers are grounded in this paper and cite their sources.
Retrospective analysis shows HCT-ALB predicts all-cause mortality in non-elderly acute pancreatitis patients, indicating potential for improved patient monitoring.
The difference between hematocrit (HCT) and plasma albumin (ALB), denoted as HCT-ALB, has been proposed as a new predictor of sepsis and infectious diseases, among others. The role of this index in predicting all-cause mortality in patients with acute pancreatitis (AP), however, has not been evaluated. The aim of this study was therefore to elucidate the correlation between HCT-ALB and 90-day all-cause mortality in non-elderly patients with AP. This retrospective cohort study utilized data from the MIMIC-IV (v1.0) database and included non-elderly adult patients diagnosed with AP who were admitted to the intensive care unit during the study. The primary outcome was the ability of HCT-ALB to predict mortality within 90 days of admission. A total of 254 patients met the inclusion criteria, and the mortality rate at 90 days after admission was 11.8%. A significant difference in HCT-ALB was observed between survivor and nonsurvivor groups, and the area under the receiver operating characteristic curve for predicting 90-day mortality was 0.692, with an optimal threshold value of 9.05 as calculated by the Youden Index. When modeled for prediction using HCT-ALB, age, and blood urea nitrogen, the predictive model showed good predictive efficacy. In conclusion, HCT-ALB serves as an independent predictor of all-cause mortality within 90 days of admission in non-elderly patients with AP. A predictive model that integrates HCT-ALB with age and serum urea nitrogen shows strong predictive efficacy.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: